The Y/C1584 mutation of von Willebrand factor in type 2M von Willebrand disease: Frequency and clearance of von Willebrand factor [4]

British Journal of Haematology

Volumn 130, Issue 3, 2005, Pages 462-463

  Millar, C M ^a   Riddel, A F ^a   Griffioe, A ^a   Jenkin, P V ^a   Brown, S A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Clearance; Mutation; Von Willebrand disease; Von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR;

CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; EXON; FOUNDER EFFECT; FREQUENCY ANALYSIS; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEMOPHILIA A; HUMAN; LETTER; PHENOTYPE; PLASMA CLEARANCE; PRIORITY JOURNAL; VON WILLEBRAND DISEASE; COHORT ANALYSIS; GENE FREQUENCY; GENETICS; METABOLIC CLEARANCE RATE; MUTATION; NOTE;

COHORT STUDIES; GENE FREQUENCY; HUMANS; METABOLIC CLEARANCE RATE; MUTATION; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 24944546745     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05637.x     Document Type: Letter

References (8)

1. Bowen D.J. Collins P.W. (2004) An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13. Blood, 103, 941 947.
2. Bowen D.J. Collins P.W. Lester W. Cumming A.M. Keeney S. Grundy P. Enayat S.M. Bolton-Maggs P.H. Keeling D.M. Khair K. Campbell Tait R. Wilde J.T. John Pasi K. Hill F.G. (2005) The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co-segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype. British Journal of Haematology, 128, 830 836.
3. Brown S.A. Eldridge A. Collins P.W. Bowen D.J. (2003) Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process? Journal of Thrombosis and Haemostasis, 1, 1714 1717.
4. van Genderen P.J. Prins F.J. Lucas I.S. van de Moesdijk D. van Vliet H.H. van Strik R. Michiels J.J. (1997) Decreased half-life time of plasma von Willebrand factor collagen binding activity in essential thrombocythaemia: normalization after cytoreduction of the increased platelet count. British Journal of Haematology, 99, 832 836.
5. Mannucci P.M. Canciani M.T. Rota L. Donovan B.S. (1981) Response of factor FVIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease. British Journal of Haematology, 47, 283 293.
6. Millar C.M. Riddell A. Jenkins P.V. Lee C.A. Brown S.A. (2004) Increased von Willebrand factor antigen clearance in type 1 von Willebrand disease: investigation of relationship with ABO blood group and Tyr1584Cys polymorphism. Blood, 104, 76a.
7. Nitu-Whalley I.C. Riddell A. Lee C.A. Pasi K.J. Owens D. Enayat M.S. Perkins S.J. Jenkins P.V. (2000) Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling. Thrombosis and Haemostasis, 86, 998 1004.
8. O'Brien L.A. James P.D. Othman M. Berber E. Cameron C. Notley C.R. Hegadorn C.A. Sutherland J.J. Hough C. Rivard G.E. O'Shaunessey D. Lillicrap D. (2003) Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease. Blood, 102, 549 557.